Placebo effect matters
Science Daily reports that learning-related brain activity in Parkinson’s patients improves as much in response to a placebo treatment as to real medication, according to a new study by researchers…
Read article
Research news
Trials of Parkinson’s vaccine show promise
The Michael J Fox Foundation reports that results from the first clinical trial of a new vaccine for Parkinson’s suggest the treatment is safe and should go forward to be…
Good news for stem cell therapies
Brazilian researchers at D’OR Institute for Research and Education (IDOR) and Federal University of Rio de Janeiro (UFRJ) have taken what they describe as an important step toward using the…
GDNF not needed by the midbrain dopamine system
A key factor in the motor symptoms associated with Parkinson’s disease is the gradual destruction of dopamine neurons. The glial cell-derived neurotrophic factor, or GDNF, has been proven to protect…
Sticky peptide may help Parkinson’s
In Parkinson’s, a protein called α-synuclein becomes misshapen and stacks together to form long toxic fibrils that kill the brain cells. A team of scientists led by the University of…
Skin test may shed new light on Alzheimer’s and Parkinson’s diseases
The 24th February issue of Science Daily reports that scientists at the Central Hospital at the University of San Luis Potosi in San Luis Potosi, Mexico have found that skin…